187 related articles for article (PubMed ID: 28209656)
41. Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.
Szuber N; Elliott M; Tefferi A
Am J Hematol; 2020 Feb; 95(2):212-224. PubMed ID: 31769070
[TBL] [Abstract][Full Text] [Related]
42. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.
Price A; Druhan LJ; Lance A; Clark G; Vestal CG; Zhang Q; Foureau D; Parsons J; Hamilton A; Steuerwald NM; Avalos BR
Biochem Biophys Res Commun; 2020 Feb; 523(1):208-213. PubMed ID: 31848046
[TBL] [Abstract][Full Text] [Related]
43. Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.
Maxson JE; Luty SB; MacManiman JD; Abel ML; Druker BJ; Tyner JW
J Biol Chem; 2014 Feb; 289(9):5820-7. PubMed ID: 24403076
[TBL] [Abstract][Full Text] [Related]
44. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications.
Mitsumori T; Komatsu N; Kirito K
Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968
[TBL] [Abstract][Full Text] [Related]
45. Chronic neutrophilic leukemia in a child with a CSF3R T618I germ line mutation.
Druhan LJ; McMahon DP; Steuerwald N; Price AE; Lance A; Gerber JM; Avalos BR
Blood; 2016 Oct; 128(16):2097-2099. PubMed ID: 27581359
[No Abstract] [Full Text] [Related]
46. T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.
Lee SE; Jo I; Jang W; Kim Y; Han K; Kim M
Ann Lab Med; 2015 May; 35(3):376-8. PubMed ID: 25932451
[No Abstract] [Full Text] [Related]
47. [Chronic neutrophilic leukemia with CSF3R mutation and concurrent multiple myeloma: one case report].
He M; Zhao XC; Bai H
Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1052. PubMed ID: 32023742
[No Abstract] [Full Text] [Related]
48. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment.
Gotlib J; Maxson JE; George TI; Tyner JW
Blood; 2013 Sep; 122(10):1707-11. PubMed ID: 23896413
[TBL] [Abstract][Full Text] [Related]
49. Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis.
Langabeer SE; Haslam K; Kelly J; Quinn J; Morrell R; Conneally E
Clin Transl Oncol; 2018 Mar; 20(3):420-423. PubMed ID: 28762112
[TBL] [Abstract][Full Text] [Related]
50. CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis.
Luo Q; Shen J; Yang Y; Tang H; Shi M; Liu J; Liu Z; Shi X; Yi Y
Br J Haematol; 2018 Mar; 180(6):892-894. PubMed ID: 27984641
[No Abstract] [Full Text] [Related]
51. [Ruxolitinib in the treatment of two cases of chronic neutrophilic leukemia].
Zheng WS; Guan LX; Cheng LC; Hu YL; Xu YY; Yang T; Peng B; Wu YL; Bo J; Wang QS; Gao XN
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):113-114. PubMed ID: 32135644
[No Abstract] [Full Text] [Related]
52. Chronic neutrophilic leukemia associated with thrombocytosis and a CSF3R Q781* nonsense mutation.
Abdulbaki R; Tizro P; Boland JL; Zonouz TH; Aggarwal A; Nava VE
Int J Lab Hematol; 2023 Jun; 45(3):e79-e82. PubMed ID: 36652962
[No Abstract] [Full Text] [Related]
53. [The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia].
Cui YJ; Jiang Q; Liu JQ; Li B; Xu ZF; Qin TJ; Zhang Y; Cai WY; Zhang HL; Fang LW; Pan LJ; Hu NB; Qu SQ; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):28-32. PubMed ID: 28219221
[No Abstract] [Full Text] [Related]
54. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW
Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature.
Wang L; Du F; Zhang HM; Wang HX
Braz J Med Biol Res; 2015 Jul; 48(7):583-7. PubMed ID: 26017341
[TBL] [Abstract][Full Text] [Related]
56. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.
Drexler HG; Nagel S; Quentmeier H
Curr Oncol; 2021 May; 28(3):1790-1794. PubMed ID: 34068566
[TBL] [Abstract][Full Text] [Related]
57. [New mutations in myeloproliferative neoplasms; 2014 update].
Kirito K
Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
[No Abstract] [Full Text] [Related]
58. CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival.
Szuber N; Finke CM; Lasho TL; Elliott MA; Hanson CA; Pardanani A; Tefferi A
Blood Cancer J; 2018 Feb; 8(2):21. PubMed ID: 29449543
[No Abstract] [Full Text] [Related]
59. A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia.
Spiciarich DR; Oh ST; Foley A; Hughes SB; Mauro MJ; Abdel-Wahab O; Press RD; Viner R; Thompson SL; Chen Q; Azadi P; Bertozzi CR; Maxson JE
Cancer Res; 2018 Dec; 78(24):6762-6770. PubMed ID: 30348809
[TBL] [Abstract][Full Text] [Related]
60. [Chronic neutrophilic leukemia complicated with multiple myeloma: two cases report and literature review].
Jiang B; Qi JY; Li QH; Xu Y; Sun MY; Zheng WW; Chen F; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):688-91. PubMed ID: 27587251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
